Cargando…
Safer opioid supply: qualitative program evaluation
BACKGROUND: As the overdose crisis in Canada continues to escalate in severity, novel interventions and programs are required. Safer Supply programs offer pharmaceutical-grade medication to people who use drugs to replace and decrease harms related to the toxic illicit drug supply. Given the paucity...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117245/ https://www.ncbi.nlm.nih.gov/pubmed/37081500 http://dx.doi.org/10.1186/s12954-023-00776-z |
_version_ | 1785028582359171072 |
---|---|
author | Haines, Marlene O’Byrne, Patrick |
author_facet | Haines, Marlene O’Byrne, Patrick |
author_sort | Haines, Marlene |
collection | PubMed |
description | BACKGROUND: As the overdose crisis in Canada continues to escalate in severity, novel interventions and programs are required. Safer Supply programs offer pharmaceutical-grade medication to people who use drugs to replace and decrease harms related to the toxic illicit drug supply. Given the paucity of research surrounding these programs, we sought to better understand the experience of being part of a Safer Supply program from the perspective of current participants. METHODS: We completed semi-structured interviews and surveys with Safer Supply participants in Ottawa, Canada. Interviews were audio-recorded, transcribed, and analyzed thematically. Descriptive statistics were used to report survey data. RESULTS: Participants most commonly discussed Safer Supply benefits. This included programs offering a sense of community, connection, hope for the future, and increased autonomy. Participants also described program concerns, such as restrictive protocols, inadequate drugs, and diversion. CONCLUSIONS: Our research demonstrated that participants found Safer Supply to be effective and impactful for their substance use goals. While participants did discuss concerns about the program, overall, we found that this is an important harm reduction-based program for people who use drugs in the midst of the overdose crisis. |
format | Online Article Text |
id | pubmed-10117245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101172452023-04-22 Safer opioid supply: qualitative program evaluation Haines, Marlene O’Byrne, Patrick Harm Reduct J Research BACKGROUND: As the overdose crisis in Canada continues to escalate in severity, novel interventions and programs are required. Safer Supply programs offer pharmaceutical-grade medication to people who use drugs to replace and decrease harms related to the toxic illicit drug supply. Given the paucity of research surrounding these programs, we sought to better understand the experience of being part of a Safer Supply program from the perspective of current participants. METHODS: We completed semi-structured interviews and surveys with Safer Supply participants in Ottawa, Canada. Interviews were audio-recorded, transcribed, and analyzed thematically. Descriptive statistics were used to report survey data. RESULTS: Participants most commonly discussed Safer Supply benefits. This included programs offering a sense of community, connection, hope for the future, and increased autonomy. Participants also described program concerns, such as restrictive protocols, inadequate drugs, and diversion. CONCLUSIONS: Our research demonstrated that participants found Safer Supply to be effective and impactful for their substance use goals. While participants did discuss concerns about the program, overall, we found that this is an important harm reduction-based program for people who use drugs in the midst of the overdose crisis. BioMed Central 2023-04-20 /pmc/articles/PMC10117245/ /pubmed/37081500 http://dx.doi.org/10.1186/s12954-023-00776-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Haines, Marlene O’Byrne, Patrick Safer opioid supply: qualitative program evaluation |
title | Safer opioid supply: qualitative program evaluation |
title_full | Safer opioid supply: qualitative program evaluation |
title_fullStr | Safer opioid supply: qualitative program evaluation |
title_full_unstemmed | Safer opioid supply: qualitative program evaluation |
title_short | Safer opioid supply: qualitative program evaluation |
title_sort | safer opioid supply: qualitative program evaluation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117245/ https://www.ncbi.nlm.nih.gov/pubmed/37081500 http://dx.doi.org/10.1186/s12954-023-00776-z |
work_keys_str_mv | AT hainesmarlene saferopioidsupplyqualitativeprogramevaluation AT obyrnepatrick saferopioidsupplyqualitativeprogramevaluation |